Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a New Pain Management Protocol Involving Intranasal Sufentanil in the Emergency Room : a Prospective Observational Study.

NCT05498831 is registered in ClinicalTrials.gov with Groupe Hospitalier de la Region de Mulhouse et Sud Alsace as lead sponsor.

NCT NCT05498831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05498831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a New Pain Management Protocol Involving Intranasal Sufentanil in the Emergency Room : a Prospective Observational Study.
Lead sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Phase
Observational
Overall status
Completed
Start date
August 9, 2022
Completion date
February 23, 2023
Enrollment
245 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain